The government has acquired an advanced system which will ensure maximum effect in the treatment of cancer.

The Cobalt 60 radiotherapy calibration system will also go a long way in minimizing side effects emanating from cancer treatment among patients.

The Cobalt 60 radiotherapy calibration system, the first of its kind in East Africa, was procured through collaboration between Kenya Bureau of Standards  (Kebs) and the International Atomic Energy Agency (IAEA).

“This cutting-edge system is poised to revolutionize cancer treatment by ensuring precise radiation doses, thereby maximizing treatment effectiveness while minimizing associated side effects,” Trade Cabinet Secretary Rebecca Miano said during the launch at Kebs.

The move has been lauded as a significant stride towards enhancing healthcare and bolstering export market competitiveness. The launch, marked a pivotal moments in the nation’s pursuit of excellence in both healthcare and industrial sectors.

Miano noted that the acquisition is a significant advancement in healthcare.

“The role of precise calibration in administering cancer treatment is crucial, and highlights its impact on patient safety and therapeutic efficacy,” the CS noted.

Kebs Managing Director, Esther Ngari emphasized the years of collaborative efforts with the IAEA, dating back to 2008, which culminated in the acquisition of the Cobalt 60 system. This collaboration, she noted, has been instrumental in fostering innovation and capacity building in cancer treatment. Meanwhile, Kebs also unveiled its Strategic Plan 2023-2027, aimed at bolstering the competitiveness of locally manufactured products in the global market.

The CS launched the plan, emphasizing the importance of adherence to quality standards in penetrating international markets. Miano highlighted the challenges faced by Kenyan enterprises in meeting stringent export market requirements, primarily attributed to non-compliance with quality control processes.